Home
Endocyte, Inc.

Endocyte, Inc. Market Share Analysis for May 2026

The General Privacy Notice for Business Partners defines Novartis data privacy rules for personal information collected and/or processed from external stakeholders (institutional decision-makers, civil servants, politicians and political decision-makers, journalists and media, patient associations, industry affiliations and influencers.

Health > Biotechnology and Pharmaceuticals

Domainendocyte.com

Year Founded1995

Employees51 - 200

Annual Revenue< $1M

Endocyte, Inc.

Endocyte, Inc. (including company regionals)

endocyte.com

See more website traffic and engagement information

Total visits to Endocyte, Inc.'s top domains

Understand Endocyte, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Endocyte, Inc.'s top domains

Analyze Endocyte, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Endocyte, Inc.'s top domains

See how Endocyte, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Endocyte, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

nektar.comCompany NameNektar TherapeuticsEmployees51 - 200HQUnited States, California, San FranciscoAnnual revenue$100M - $200MTotal visits35.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Endocyte, Inc.

These are the website technologies, by industry, used by Endocyte, Inc. top domains

Audio Video Media (4)

YouTube

Widget (4)

Twemoji

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Endocyte, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPluvicto acquired Endocyte for $2.1B on Jan 1st '18.Novartis acquired the rights to Pluvicto when it bought West Lafayette-based startup Endocyte Inc. for $2.1 billion in 2018.

NewsNovartis Pharmaceuticals Canada, Inc. acquired Endocyte on Oct 1st '18.Novartis announced the acquisition of Endocyte in October 2018 which will help the company to strengthen them in the radiopharmaceuticals so they can use better technology to treat cancer.

NewsEndocyte acquired Novartis Pharmaceuticals Corporation for $2.1B on Jan 1st '18.Ten Purdue startups have been acquired by major national or international companies, including Endocyte Inc., which was acquired in 2018 for $2.1 billion by Swiss pharmaceutical giant Novartis AG.